Benzinga's Top #PreMarket Gainers

shares rose 7.43 percent to $25.01 in pre-market trading as the company issued a stronger-than-expected third-quarter and fiscal-year 2016 guidance.

shares rose 6.56 percent to $5.85 in pre-market trading following the announcement of positive phase 3 cabozantinib trial results.

shares rose 4.69 percent to $69.85 in pre-market trading. Goldman Sachs upgraded First Solar from Neutral to Buy and raised the price target from $61.00 to $100.00.

shares rose 4.64 percent to $29.30 in pre-market trading. Goldman Sachs added SolarEdge Technologies to its Conviction Buy list and raised the price target from $32.00 to $41.00.

shares rose 4.46 percent to $11.00. Mazor Robotics reported orders for 12 Renaissance systems in the fourth quarter and issued a strong Q4 revenue forecast.